相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction
Sadayoshi Ito et al.
HYPERTENSION RESEARCH (2021)
Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism
Ryo Nakamaru et al.
HYPERTENSION (2021)
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
W. F. Young
JOURNAL OF INTERNAL MEDICINE (2019)
Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)
Sadayoshi Ito et al.
HYPERTENSION (2019)
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term
Gian Paolo Rossi et al.
HYPERTENSION (2018)
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study
Gregory L. Hundemer et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment
Anand Vaidya et al.
ENDOCRINE REVIEWS (2018)
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice
Silvia Monticone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
John W. Funder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study
Kazuaki Shimamoto et al.
HYPERTENSION RESEARCH (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
Paolo Mulatero et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
What is the Best Criterion for the Interpretation of Adrenal Vein Sample Results in Patients with Primary Hyperaldosteronism?
Richard Webb et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications
Graziela Z. Kalil et al.
HYPERTENSION RESEARCH (2012)
Age As a Risk Factor
Ravi Dhingra et al.
MEDICAL CLINICS OF NORTH AMERICA (2012)
Guidelines for the diagnosis and treatment of primary aldosteronism - The Japan Endocrine Society 2009
Tetsuo Nishikawa et al.
ENDOCRINE JOURNAL (2011)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss - An update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
P Poirier et al.
CIRCULATION (2006)
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
P Milliez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Role for adrenal venous sampling in primary aldosteronism
WF Young et al.
SURGERY (2004)
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
MH Weinberger et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
Gender differences in the regulation of blood pressure
JF Reckelhoff
HYPERTENSION (2001)